Scendea


Scendea logo

Scendea was founded as a result of a management buyout of the product development and regulatory consulting function of a clinical research organisation. Our origin dates back over 20 years, with involvement in over 1,000 development programmes.

Scendea's expert team delivers strategic and operational support in the fields of quality/CMC, non-clinical/toxicology, clinical/medical and regulatory to successfully guide products from early development to marketing approval.

A combination of scientific excellence, industry experience, commercial awareness and a collaborative approach allow our expert team to solve complex issues associated with medicinal product development. Scendea has team members based in the UK, Ireland, the Netherlands and the US, who deliver innovative and high-quality solutions aligned to jurisdiction-specific regulatory requirements.

At Scendea we collaborate, innovate, and together with our clients, we succeed.

Contact Scendea via their website


News archive

25/11/2020   Meet Scendea at 5 forthcoming events including Biotech Showcase...more
27/10/2020   Read Scendea's BIA-MHRA Regulatory Innovation Conference Report...more
20/07/2020   Scendea Discusses Novel Methodologies for Modern Drug Development...more
29/06/2020   Scendea Discusses Engaging With Regulators on Novel Statistical Approaches...more
15/06/2020   Scendea : Making The Most of Opportunities to Interact With EU Regulators...more
29/05/2020   Scendea Advises Consideration For Cell Therapies...more
01/06/2020   Scendea joins the BioPartner programme...more

The BioPartner Programme

BPP members enjoy our full range of discounts, enhanced promotion on BioPartner UK Delegations and first refusal on new international opportunities.

Not a member? Join the BioPartnership Programme

BioPartner UK is a member of

Sponsors Alliance

Prompt Payment Code